DK1853241T3 - Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyclohexandion ved behandling af Parkinson's sygdom - Google Patents
Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyclohexandion ved behandling af Parkinson's sygdomInfo
- Publication number
- DK1853241T3 DK1853241T3 DK06709910.1T DK06709910T DK1853241T3 DK 1853241 T3 DK1853241 T3 DK 1853241T3 DK 06709910 T DK06709910 T DK 06709910T DK 1853241 T3 DK1853241 T3 DK 1853241T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- parkinson
- treatment
- trifluoromethylbenzoyl
- cyclohexanedione
- Prior art date
Links
- 208000018737 Parkinson disease Diseases 0.000 title abstract 3
- OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 title abstract 2
- 229940125782 compound 2 Drugs 0.000 abstract 2
- 230000004770 neurodegeneration Effects 0.000 abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0504103.3A GB0504103D0 (en) | 2005-02-28 | 2005-02-28 | Novel method |
| PCT/GB2006/000684 WO2006090177A1 (en) | 2005-02-28 | 2006-02-27 | USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1853241T3 true DK1853241T3 (da) | 2012-01-16 |
Family
ID=34430351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06709910.1T DK1853241T3 (da) | 2005-02-28 | 2006-02-27 | Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyclohexandion ved behandling af Parkinson's sygdom |
Country Status (17)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101669432B1 (ko) * | 2007-08-27 | 2016-10-26 | 다트 뉴로사이언스 (케이만) 엘티디. | 치료적 이속사졸 화합물 |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| BRPI0921431A2 (pt) * | 2008-11-06 | 2017-06-06 | Biotie Therapies Ag | método para tratar ou prevenir síndrome das pernas inquietas, composição farmacêutica, e, métodos para tratar ou prevenir distúrbios do sono, e para melhorar a quantidade do sono ou adequação do sono |
| HRP20160286T1 (hr) * | 2011-06-23 | 2016-05-06 | Swedish Orphan Biovitrum International Ab | Tekuća farmaceutska kompozicija koja sadrži nitizinon |
| CN103622942A (zh) * | 2013-11-04 | 2014-03-12 | 江苏大学 | 左旋多巴/卡比多巴复方缓释混悬剂及其制备方法 |
| EP3328381A1 (en) * | 2015-07-29 | 2018-06-06 | Takeda GmbH | Pde4 inhibitor for the treatment of diabetic nephropathy |
| ITUB20160650A1 (it) | 2016-02-11 | 2017-08-11 | Dipharma S A | Formulazioni farmaceutiche solide stabili contenenti 2-(2-nitro-4-trifluorometilbenzoil)-1,3-cicloesandione |
| US9783485B1 (en) | 2016-11-30 | 2017-10-10 | Dipharma S.A. | Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4780127A (en) * | 1982-03-25 | 1988-10-25 | Stauffer Chemical Company | Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides |
| US5092919A (en) * | 1991-01-15 | 1992-03-03 | Imperial Chemical Industries Plc | Certain 2-(2'-methyl-3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones |
| WO1993000080A1 (en) * | 1991-06-24 | 1993-01-07 | Zeneca Ltd. | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| FR2777781B1 (fr) * | 1998-04-24 | 2004-04-09 | Rhone Poulenc Rorer Sa | Associations riluzole et l-dopa pour le traitement de la maladie de parkinson |
| US20050288187A1 (en) * | 2002-07-03 | 2005-12-29 | Hanauske-Abel Hartmut M | Inhibitor development for 4-hydroxyphenylpyruvate dioxygenase, employing tyrosinemia 1 as a model for human diseases mediated by 2-oxoacid utilizing dioxygenases |
| US20060166972A1 (en) * | 2003-07-11 | 2006-07-27 | Conn P J | Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| JP2010501532A (ja) * | 2006-08-18 | 2010-01-21 | シンジェンタ リミテッド | うつ病、および／または常習性薬物の使用に伴う禁断症状の治療のための、ｈｐｐｄ阻害薬の使用 |
| BRPI0921431A2 (pt) * | 2008-11-06 | 2017-06-06 | Biotie Therapies Ag | método para tratar ou prevenir síndrome das pernas inquietas, composição farmacêutica, e, métodos para tratar ou prevenir distúrbios do sono, e para melhorar a quantidade do sono ou adequação do sono |
-
2005
- 2005-02-28 GB GBGB0504103.3A patent/GB0504103D0/en not_active Ceased
-
2006
- 2006-02-27 CA CA002598517A patent/CA2598517A1/en not_active Abandoned
- 2006-02-27 PT PT06709910T patent/PT1853241E/pt unknown
- 2006-02-27 RU RU2007131934/15A patent/RU2420272C2/ru not_active IP Right Cessation
- 2006-02-27 AU AU2006217650A patent/AU2006217650B2/en not_active Ceased
- 2006-02-27 WO PCT/GB2006/000684 patent/WO2006090177A1/en not_active Ceased
- 2006-02-27 AT AT06709910T patent/ATE524171T1/de active
- 2006-02-27 ES ES06709910T patent/ES2374761T3/es active Active
- 2006-02-27 ZA ZA200707486A patent/ZA200707486B/xx unknown
- 2006-02-27 DK DK06709910.1T patent/DK1853241T3/da active
- 2006-02-27 US US12/090,645 patent/US20090326072A1/en not_active Abandoned
- 2006-02-27 CN CN2006800133878A patent/CN101163466B/zh not_active Expired - Fee Related
- 2006-02-27 BR BRPI0609177-6A patent/BRPI0609177A2/pt not_active IP Right Cessation
- 2006-02-27 JP JP2007557572A patent/JP2008531665A/ja active Pending
- 2006-02-27 EP EP06709910A patent/EP1853241B1/en active Active
- 2006-02-27 MX MX2007010480A patent/MX2007010480A/es not_active Application Discontinuation
-
2007
- 2007-08-21 IL IL185410A patent/IL185410A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0504103D0 (en) | 2005-04-06 |
| WO2006090177A1 (en) | 2006-08-31 |
| AU2006217650B2 (en) | 2011-06-09 |
| EP1853241B1 (en) | 2011-09-14 |
| MX2007010480A (es) | 2008-02-07 |
| RU2420272C2 (ru) | 2011-06-10 |
| RU2007131934A (ru) | 2009-02-27 |
| ES2374761T3 (es) | 2012-02-21 |
| CN101163466B (zh) | 2011-12-07 |
| EP1853241A1 (en) | 2007-11-14 |
| CN101163466A (zh) | 2008-04-16 |
| PT1853241E (pt) | 2012-01-11 |
| US20090326072A1 (en) | 2009-12-31 |
| JP2008531665A (ja) | 2008-08-14 |
| AU2006217650A1 (en) | 2006-08-31 |
| BRPI0609177A2 (pt) | 2010-02-23 |
| ZA200707486B (en) | 2009-02-25 |
| CA2598517A1 (en) | 2006-08-31 |
| IL185410A0 (en) | 2008-08-07 |
| ATE524171T1 (de) | 2011-09-15 |
| HK1110211A1 (en) | 2008-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
| DK2303330T4 (da) | Farmaceutiske sammensætninger til behandling af parkinsons sygdom | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| EP1940373B8 (en) | 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease | |
| CL2008001960A1 (es) | Compuestos derivados de tetrahidropiranocromano, procedimiento de preparacion, composicion farmaceutica, util para inhibir gamma-secretasa, destinados al tratamiento de enfermedades neurodegenetarivas, enfermedad de alzheimer e inhibir el deposito de proteina amiloide. | |
| IL185410A0 (en) | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of parkinson's disease | |
| DK1670903T3 (da) | Behandling af neurodegenerative sygdomme | |
| EP2048141A4 (en) | OPTICALLY PURE DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF VIRUSES | |
| DK1778837T3 (da) | Behandling af neurodegenerative sygdomme ved anvendelse af SCD4-inhibitorer | |
| AR068438A1 (es) | Derivado de 6-pirimidinil-pirimid-2-ona | |
| CL2007003189A1 (es) | Compuestos derivados de indol y benzofurano; composicion farmaceutica; y uso para el tratamiento o la prevencion de la enfermedad de alzheimer. | |
| DK1847524T3 (da) | Terphenylderivater til behandling af Alzheimers sygdom | |
| AR068439A1 (es) | Derivado de 6-pirimidinil-pirimid-2-ona | |
| DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
| TW200716152A (en) | Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture | |
| DE602006005640D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| WO2007017511A3 (de) | Verbindungen zur behandlung der alzheimer erkrankung | |
| DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| DK1778623T3 (da) | Derivater af 1-phenylalkancarboxylsyrer til behandling af neurodegenerative sygdomme | |
| DE602007008947D1 (en) | 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3-modulatoren | |
| ATE502947T1 (de) | 4,5,6,7-tetrahydrothienoä3,2-cüpyridinderivate als h3-modulatoren | |
| HK1164058A (en) | Specific diarylhydantoin and diarylthiohydantoin compounds | |
| TH80754A (th) | สารประกอบอะมิโนเบนโซฟีโนนที่ถูกแทนที่ด้วยไทรเอโซล |